NIKKEI 225
39,667.07 +493.92 (+1.26%) HANG SENG
18,089.93 +17.03 (+0.09%) CRUDE OIL
81.08 +0.25 (+0.31%) GOLD FUTURES
2,312.60 -18.20 (-0.78%) DOW
39,157.85 +45.69 (+0.12%) Bitcoin GBP
48,313.98 -376.40 (-0.77%)
PODD Oct 2024 170.000 call
| Previous close | 32.20 |
| Open | 32.20 |
| Bid | 41.00 |
| Ask | 44.40 |
| Strike | 170.00 |
| Expiry date | 2024-10-18 |
| Day's range | 32.20 - 32.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Barrons.comInsulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
Automated pumps are already used by about 40% of those with the autoimmune version of diabetes, known as Type-1. Insulet is aiming at the shallowly penetrated market of patients with Type-2.Read the full ...
ZacksESLOY vs. PODD: Which Stock Is the Better Value Option?
ESLOY vs. PODD: Which Stock Is the Better Value Option?
BloombergLilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
(Bloomberg) -- The new class of weight-loss drugs being tested as cure-alls for everything from knee replacements to liver disease keeps throwing corners of the stock market into disarray.Most Read from BloombergNvidia’s 13% Stock Rout Has Traders Scouring Charts for SupportBuzzFeed Struggles to Sell Owner of Hit YouTube Show ‘Hot Ones’Jain Global Raises $5.3 Billion, Secures Cash From Abu DhabiHow Long Can High Rates Last? Bond Markets Say Maybe ForeverWikileaks’ Julian Assange to Plead Guilty,
